Receptor News and Research

RSS

MD Anderson and National Resilience launch the Cell Therapy Manufacturing Center

The University of Texas MD Anderson Cancer Center and National Resilience, Inc., today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer.

2 Jun 2022

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Aerobic exercise reprograms the immune system to reduce pancreatic tumor growth and amplify the effects of immunotherapy, a new study finds.

2 Jun 2022

New findings by HBP researchers provide a better understanding of human brain organization

Specific cellular, molecular and gene expression patterns in brain areas are linked to function, but their precise relationships remain largely unknown.

2 Jun 2022

Scientists characterize a novel zoonotic coronavirus in humans

Scientists characterize the spike protein structure, entry receptors, and antigenicity of the newly emerged CCoV-HuPn-2018.

2 Jun 2022

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Researchers looked into the role played by the accessory proteins using synthetic genomics assembly technology

2 Jun 2022

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

Researchers at the University of Michigan Rogel Cancer Center have found a cell nuclear receptor activated by high fat diets and synthetic substances in unregulated athletic performance enhancers fuels the progression of precancerous pancreas lesions into pancreatic cancer.

1 Jun 2022

Study identifies how ketamine works as a rapid antidepressant

Ketamine is the speedster of antidepressants, working within hours compared to more common antidepressants that can take several weeks. But ketamine can only be given for a limited amount of time because of its many side effects.

1 Jun 2022

People with food allergies less likely to become infected with SARS-CoV-2, study finds

A National Institutes of Health-funded study has found that people with food allergies are less likely to become infected with SARS-CoV-2, the virus that causes COVID-19, than people without them. In addition, while previous research identified obesity as a risk factor for severe COVID-19, the new study has identified obesity and high body mass index (BMI) as associated with increased risk for SARS-CoV-2 infection.

1 Jun 2022

Inverse relationship identified between SARS-CoV-2 and influenza infections

A new study identifies the potential correlations that exist between SARS-CoV-2 and influenza infections.

1 Jun 2022

COVID-19 infections during the Omicron wave in unvaccinated US adults

Researchers assessed the incidence of SARS-CoV-2 infections during the prevalence of the SARS-CoV-2 Omicron variant.

1 Jun 2022

Scientists discover a new role for protein complex at the center of Bardet-Biedl syndrome

Scientists have identified a new role for a protein complex at the center of a human genetic disorder called Bardet-Biedl syndrome, or BBS, for which there is currently no cure.

31 May 2022

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

Researchers evaluated the impact of CMV seropositivity on humoral and cellular immune responses generated after double and/or triple mRNA vaccination against SARS-CoV-2 among the elderly.

31 May 2022

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

Scientists demonstrated that the pineapple-derived jacalin-related lectin (AcmJRL/AnLec) could be an anti-SARS-CoV-2 agent.

31 May 2022

New compounds for cancer immunotherapy via STING-mediated immune activation

Innovations in cancer immunotherapy have achieved clinical success by considerably increasing the survival rate of patients undergoing cancer treatment.

31 May 2022

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Researchers assessed the neutralizing activity against SARS-CoV-2 Omicron variant after tixagevimab plus cilgavimab (T+C) administration.

30 May 2022

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identified 10-40, a human monoclonal antibody with potent neutralizing activity against SARS-CoV, SARS-CoV-2, and related sarbecoviruses.

30 May 2022

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Researchers explored the virological profiles of novel SARS-CoV-2 Omicron variants.

30 May 2022

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Researchers reported findings of a systematic antigenic analysis of the circulating SARS-CoV-2 Omicron subvariants such as BA.2.12.1, BA.4, and BA.5.

30 May 2022

Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

Researchers reported a method to predict neutralization and protection against SARS-CoV-2 antigens.

30 May 2022

Direct comparison of immune memory responses to four COVID-19 vaccines

Researchers evaluated host immune responses to four COVID-19 vaccines representing three different vaccine technology platforms, focusing on immune memory responses.

30 May 2022

Receptor News and Research

MD Anderson and National Resilience launch the Cell Therapy Manufacturing Center

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

New findings by HBP researchers provide a better understanding of human brain organization

Scientists characterize a novel zoonotic coronavirus in humans

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

Study identifies how ketamine works as a rapid antidepressant

People with food allergies less likely to become infected with SARS-CoV-2, study finds

Inverse relationship identified between SARS-CoV-2 and influenza infections

COVID-19 infections during the Omicron wave in unvaccinated US adults

Scientists discover a new role for protein complex at the center of Bardet-Biedl syndrome

The effect of CMV serostatus on humoral and cellular measures of vaccine responses after 2 and 3 doses of SARS-CoV-2 mRNA vaccines in older adults

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

New compounds for cancer immunotherapy via STING-mediated immune activation

Evaluating tixagevimab plus cilgavimab against SARS-CoV-2

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Method for predicting neutralization and protection based on variant-specific antibody measurements to SARS-CoV-2 antigens

Direct comparison of immune memory responses to four COVID-19 vaccines

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News